238 related articles for article (PubMed ID: 33910814)
1. Radiotherapy and Renal Cell Carcinoma: A Continuing Saga.
Spyropoulou D; Tsiganos P; Dimitrakopoulos FI; Tolia M; Koutras A; Velissaris D; Lagadinou M; Papathanasiou N; Gkantaifi A; Kalofonos H; Kardamakis D
In Vivo; 2021; 35(3):1365-1377. PubMed ID: 33910814
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy in renal cell carcinoma.
De Felice F; Tombolini V
Crit Rev Oncol Hematol; 2018 Aug; 128():82-87. PubMed ID: 29958634
[TBL] [Abstract][Full Text] [Related]
3. Current Role of Radiotherapy for Renal-Cell Carcinoma: Review.
Dengina N; Tsimafeyeu I; Mitin T
Clin Genitourin Cancer; 2017 Apr; 15(2):183-187. PubMed ID: 27789182
[TBL] [Abstract][Full Text] [Related]
4. [Not Available].
Mery B; Rancoule C; Rowinski E; Bosacki C; Vallard A; Guy JB; Magné N
Bull Cancer; 2018 Dec; 105 Suppl 3():S280-S285. PubMed ID: 30595157
[TBL] [Abstract][Full Text] [Related]
5. Role of radiotherapy in the treatment of renal cell cancer: updated and critical review.
Fusco V; Parisi S; d'Andrea B; Troiano M; Clemente MA; Morelli F; Caivano R; Guglielmi G
Tumori; 2017 Nov; 103(6):504-510. PubMed ID: 28604998
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
Carrasco-Esteban E; Barrionuevo-Castillo P; Domínguez-Rullán J; Gómez-Aparicio MA; Ferri-Molina M; Sáez-Bueno P; Zalabarría-Zarrabeitia Z; Scorsetti M; Arcangeli S; López-Campos F; Couñago F
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):163-176. PubMed ID: 36443137
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit with resection of brain metastases from renal cell carcinoma in the setting of molecular targeted therapy and/or immune therapy.
Huntoon K; Damante M; Wang J; Olencki T; Elder JB
Curr Probl Cancer; 2022 Apr; 46(2):100805. PubMed ID: 34836657
[TBL] [Abstract][Full Text] [Related]
8. Role of Radiation in Treatment of Renal Cell Carcinoma.
Leeman JE
Hematol Oncol Clin North Am; 2023 Oct; 37(5):921-924. PubMed ID: 37246085
[TBL] [Abstract][Full Text] [Related]
9. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
Miccio JA; Oladeru OT; Jun Ma S; Johung KL
Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for renal-cell carcinoma.
De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
[TBL] [Abstract][Full Text] [Related]
12. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
13. The Reintroduction of Radiotherapy Into the Integrated Management of Kidney Cancer.
Dohopolski M; Hannan R; Wardak Z; Hammers H; Garant A
Cancer J; 2020; 26(5):448-459. PubMed ID: 32947313
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
[TBL] [Abstract][Full Text] [Related]
15. Radiation Therapy in the Treatment of Localized and Advanced Renal Cancer.
Yim K; Leeman JE
Urol Clin North Am; 2023 May; 50(2):325-334. PubMed ID: 36948675
[TBL] [Abstract][Full Text] [Related]
16. [A systematic review of radiotherapy for primary renal cell carcinoma].
Gladilina IA; Shabanov MA; Kushlinskii NE; Bliganov PI; Sergeev AN
Urologiia; 2022 Mar; (1):96-101. PubMed ID: 35274868
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
[TBL] [Abstract][Full Text] [Related]
18. The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma.
Ali M; Mooi J; Lawrentschuk N; McKay RR; Hannan R; Lo SS; Hall WA; Siva S
Eur Urol; 2022 Dec; 82(6):613-622. PubMed ID: 35843777
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Trends in the Utilization of Radiotherapy in Patients With Renal Cell Carcinoma.
Shaikh T; Handorf EA; Murphy CT; Kutikov A; Uzzo RG; Hallman M; Horwitz EM; Smaldone MC
Urology; 2015 Dec; 86(6):1165-73. PubMed ID: 26383611
[TBL] [Abstract][Full Text] [Related]
20. Durable control of locally recurrent renal cell carcinoma using stereotactic body radiotherapy.
Maclean J; Breau RH; Scheida N; Malone S
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25199199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
